Journal of Ophthalmic and Optometric Sciences

Vol. 7 No. 3 (2023)

Electrophysiological Eye Examination of a Patient Suffering from Tuberous Sclerosis and Probable Retinal Dystrophy

Journal of Ophthalmic and Optometric Sciences, Vol. 7 No. 3 (2023), 24 June 2023 , Page 39-41
https://doi.org/10.22037/joos.v7i3.46390

Abstract

A twelve-year-old girl suffering from tuberous sclerosis complex was referred to Basir Eye Clinic, Tehran, Iran, for electrophysiological eye examinations, including visual evoked potential (VEP) and electroretinography (ERG). The patient's medical history showed that she experienced seizures at the age of ten, for which treatment with vigabatrin was initiated. Her field of vision was abnormal, potentially due to the side effects of vigabatrin. The ERG results were also abnormal.

Keywords:
  • Tuberous Sclerosis
  • Retinal Dystrophy
  • Electrophysiology
  • Visual Evoked Potential
  • Electroretinography

How to Cite

Shushtarian, S. M. M., Mahvelati Shams Abadi, F., & Adhami-Moghadam, F. (2024). Electrophysiological Eye Examination of a Patient Suffering from Tuberous Sclerosis and Probable Retinal Dystrophy. Journal of Ophthalmic and Optometric Sciences, 7(3), 39–41. https://doi.org/10.22037/joos.v7i3.46390

References

Islam MP. Tuberous Sclerosis Complex. Semin Pediatr Neurol. 2021;37:100875.

Nabbout R, Kuchenbuch M, Chiron C, Curatolo P. Pharmacotherapy for Seizures in Tuberous Sclerosis Complex. CNS Drugs. 2021;35(9):965-83.

Jeong A, Nakagawa JA, Wong M. Predictors of Drug-Resistant Epilepsy in Tuberous Sclerosis Complex. J Child Neurol. 2017;32(14):1092-8.

Bresnahan R, Gianatsi M, Maguire MJ, Tudur Smith C, Marson AG. Vigabatrin add-on therapy for drug-resistant focal epilepsy. Cochrane Database Syst Rev. 2020;7(7):CD007302.

Harding GF, Robertson K, Spencer EL, Holliday I. Vigabatrin; its effect on the electrophysiology of vision. Doc Ophthalmol. 2002;104(2):213-29.

Gross-Tsur V, Banin E, Shahar E, Shalev RS, Lahat E. Visual impairment in children with epilepsy treated with vigabatrin. Ann Neurol. 2000;48(1):60-4.

Hawker MJ, Astbury NJ. The ocular side effects of vigabatrin (Sabril): information and guidance for screening. Eye (Lond). 2008;22(9):1097-8.

Hilton EJ, Hosking SL, Betts T. The effect of antiepileptic drugs on visual performance. Seizure. 2004;13(2):113-28.

Shushtarian SMM, Pour Mazar R. Self-withdrawal of Levetiracetam in a Patient with Epilepsy Leading to Blindness. Journal of Ophthalmic and Optometric Sciences. 2023;7(1): 28-30.

  • Abstract Viewed: 73 times
  • pdf Downloaded: 74 times

Download Statastics

Current Issue